General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Esperion(MODEST), Abbott Diagnostic(MODEST), AstraZeneca(SIGNIFICANT), Roche Diagnostic(MODEST), Amgen(SIGNIFICANT), Denka Seiken(SIGNIFICANT), Ionis(SIGNIFICANT), New Amsterdam(MODEST), Eli Lilly and Company(SIGNIFICANT), Merck & Co., Inc.(SIGNIFICANT), Amarin(MODEST), Arrowhead(SIGNIFICANT), Novartis(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Novartis(SIGNIFICANT), Abbott Diagnostic(SIGNIFICANT), Akcea(SIGNIFICANT), Amgen(SIGNIFICANT), Arrowhead(SIGNIFICANT), Merck & Co., Inc.(SIGNIFICANT), Novo Nordisk Inc.(SIGNIFICANT), New Amsterdam(SIGNIFICANT), Ionis(SIGNIFICANT)

View Full Disclosure